Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
Synonyms :
Class :
may enhance the therapeutic efficacy of each other when used in combination
may enhance the therapeutic efficacy of each other when used in combination
may enhance the therapeutic efficacy of each other when used in combination
may enhance the therapeutic efficacy of each other when used in combination
may enhance the therapeutic efficacy of each other when used in combination
may diminish the therapeutic efficacy of each other when used in combination
may diminish the therapeutic efficacy of each other when used in combination
may diminish the therapeutic efficacy of each other when used in combination
may diminish the therapeutic efficacy of each other when used in combination
may diminish the therapeutic efficacy of each other when used in combination
choline magnesium trisalicylate
Salicylates may enhance the risk of adverse effects of Carbonic Anhydrase Inhibitors
choline magnesium trisalicylate
may have an increasingly adverse effect when combined with carbonic anhydrase inhibitors
may enhance the rate of excretion resulting in the lower serum level
may enhance the rate of excretion resulting in the lower serum level
may enhance the rate of excretion resulting in the lower serum level
may enhance the rate of excretion resulting in the lower serum level
may enhance the rate of excretion resulting in the lower serum level
may diminish the excretion rate of amantadine
carbonic Anhydrase Inhibitors may reduce the rate of excretion of amphetamines
carbonic Anhydrase Inhibitors may reduce the rate of excretion of amphetamines
carbonic Anhydrase Inhibitors may reduce the rate of excretion of amphetamines
may decrease the rate of excretion of amphetamines
may decrease the rate of excretion of amphetamines
may decrease the rate of excretion of amphetamines
may decrease the rate of excretion of amphetamines
may decrease the rate of excretion of amphetamines
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may enhance the serum concentration when combined with alpha-/beta-agonists
diclofenamide: it may decrease the excretion rate of metheglobinemia associated agents
diclofenamide: it may decrease the excretion rate of metheglobinemia associated agents
diclofenamide: it may decrease the excretion rate of metheglobinemia associated agents
diclofenamide: it may decrease the excretion rate of metheglobinemia associated agents
diclofenamide: it may decrease the excretion rate of metheglobinemia associated agents
it may increase the level of serum concentration of memantine 
it may decrease the rate of excretion of amphetamines 
it may increase the level of serum concentration of memantine
carbonic Anhydrase Inhibitors may increase the levels of serum concentration of amantadine
carbonic Anhydrase Inhibitors may decrease the levels of serum concentration of lithium
carbonic Anhydrase Inhibitors may increase the risk of adverse effects of metformin
Carbonic Anhydrase Inhibitors may increase the levels of serum concentration of Alpha-/Beta-Agonists
carbonic anhydrase inhibitors may enhance the levels of serum concentration of alpha-/beta-agonists
they increase the toxicity of metformin
choline magnesium trisalicylate
may enhance the adverse effect of carbonic anhydrase inhibitors
may diminish the excretion of amphetamines
may enhance the serum concentration of amantadine
may increase the levels of serum concentration
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the hypoglycemic effect of Antidiabetic Agents
they increase the toxicity of saxagliptin/metformin